How genetics shape the GLP-1 experience Side-effect tolerability is shaped by many factors, including dose-escalation strategy, baseline gastrointestinal motility, hydration status, concurrent medications, prior GLP-1 exposure, metabolic health, and individual biology
The first clinical study of an oral small-molecule GLP-1 receptor agonist suggests effective glycemic control and weight loss in patients with type 2 diabetes
For patients currently using or considering compounded GLP-1 medications, the most important practical step is to work with a reputable, properly licensed pharmacy and a licensed healthcare provider who can compare the evolving regulatory space on your behalf
If you have a severe vitamin B12 deficiency, you might feel a significant boost almost immediately
There should be a low threshold for treating possible urinary tract infections